Quantitative urine proteomics in pregnant women for the identification of predictive biomarkers for preeclampsia

被引：0
作者：
Sakari Joenväärä
Matilda Holm
Mayank Saraswat
Rahul Agarwal
Tiialotta Tohmola
Eero Kajantie
Katri Räikkönen
Hannele Laivuori
Pia M. Villa
Esa Hämäläinen
Risto Renkonen
机构：
[1] University of Helsinki and Helsinki University Hospital,Transplantation laboratory, Faculty of Medicine
[2] Mayo Clinic,Present address: Department of Laboratory Medicine and Pathology
[3] All India Institute of Medical Sciences,Department of Reproductive Biology
[4] Finnish Institute for Health and Welfare,Children’s Hospital
[5] University of Helsinki and Helsinki University Hospital,PEDEGO Research Unit, MRC Oulu
[6] Oulu University Hospital and University of Oulu,Department of Psychology and Logopedics, Faculty of Medicine
[7] University of Helsinki and Helsinki University Hospital,Department of Obstetrics and Gynecology
[8] Tampere University Hospital,Faculty of Medicine and Health Technology
[9] Tampere University,Department of Medical and Clinical Genetics, Faculty of Medicine
[10] University of Helsinki and Helsinki University Hospital,Institute for Molecular Medicine Finland, Helsinki Institute of Life Science
[11] University of Helsinki,Department of Obstetrics and Gynecology
[12] University of Helsinki and Helsinki University Hospital,Hyvinkää Hospital
[13] Helsinki and Uusimaa Hospital District,Department of Clinical Chemistry
[14] University of Helsinki and Helsinki University Hospital,Department of Clinical Chemistry, Institute of Clinical Medicine
[15] University of Eastern Finland,undefined
[16] Kuopio University Hospital,undefined
来源：
Translational Medicine Communications | / 7卷 / 1期
关键词：
Preeclampsia; Prediction; Biomarkers; Proteomics; Mass spectrometry; Urine;
D O I：
10.1186/s41231-022-00108-6
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 121 条
  • [1] Lisonkova S(2013)Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease Am J Obstet Gynecol 209 544-644
  • [2] Joseph KS(2010)Pre-eclampsia Lancet 376 631-622
  • [3] Steegers EA(2017)Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia N Engl J Med 377 613-1798
  • [4] von Dadelszen P(2007)Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data Lancet. 369 1791-556
  • [5] Duvekot JJ(2012)Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis Am J Perinatol 29 551-33
  • [6] Pijnenborg R(2013)Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort BMC Pregnancy Childbirth 13 110-506
  • [7] Rolnik DL(2016)Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation Am J Obstet Gynecol 214 103-569
  • [8] Wright D(2019)The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention Int J Gynaecol Obstet 145 1-43
  • [9] Poon LC(2015)Urine proteomic studies in preeclampsia Proteomics Clin Appl 9 501-74
  • [10] O'Gorman N(2008)Proteomic profiling of urine identifies specific fragments of SERPINA1 and albumin as biomarkers of preeclampsia Am J Obstet Gynecol 199 551-131g
12345678910